|
시장보고서
상품코드
2045763
미용의학 시장 : 기회, 성장 촉진요인, 업계 동향 분석 및 예측(2026-2035년)Aesthetic Medicine Market Opportunity, Growth Drivers, Industry Trend Analysis, and Forecast 2026 - 2035 |
||||||
세계의 미용의학 시장은 2025년에 232억 달러로 평가되었고 CAGR 13.5%를 나타내 2035년까지 802억 달러에 이를 것으로 예측됩니다.
성형수술에 대한 인식 증가, 의료 및 미용 기술의 지속적인 발전, 비침습적 치료에 대한 선호도 증가에 힘입어 시장은 강력한 성장세를 보이고 있습니다. 비만과 신체 이미지에 대한 관심이 높아지면서 외모를 개선하기 위해 미용의학를 찾는 사람들이 늘어남에 따라 시장 확대에 더욱 기여하고 있습니다. 미용기기와 치료법의 기술 혁신으로 안전성, 정확성, 치료결과가 향상되어 시술이 더욱 친숙하고 매력적으로 다가오고 있습니다. 또한, 성형에 대한 사회적 인식의 변화와 더불어 가처분 소득 증가와 다양한 연령층의 미용 치료 수용 확대가 지속적인 수요를 뒷받침하고 있습니다. 피부과 및 전문 미용 센터의 확대는 고급 시술에 대한 접근성을 향상시켜 세계 시장 침투를 더욱 강화하고 있습니다.
| 시장 범위 | |
|---|---|
| 시작 연도 | 2025년 |
| 예측 기간 | 2026-2035년 |
| 시작 연도 시장 규모 | 232억 달러 |
| 예측 금액 | 802억 달러 |
| CAGR | 13.5% |
미용의학는 외과적 시술, 최소 침습적 시술, 비수술적 시술을 통해 외모를 개선하는 데 초점을 맞춘 의료 분야를 말합니다. 주름, 흉터, 여분의 지방, 피부 처짐, 셀룰라이트, 불필요한 체모, 불규칙한 색소침착 등의 고민을 해결해줍니다. 이러한 시술은 피부과 전문의, 성형외과 전문의, 미용의료 종사자 등 자격을 갖춘 전문가가 시행합니다. 미용 성형에 대한 수용도가 높아지면서 외모와 자신감을 높이기 위한 시술을 찾는 사람들이 늘어나면서 수요가 크게 증가하고 있습니다. 전 세계 비만율 증가도 주요 성장 요인으로 작용하고 있으며, 식습관이나 운동과 같은 전통적인 생활습관 개선법을 넘어 더 나은 바디 컨투어링 효과를 얻기 위해 미용 시술을 선택하는 사람들이 늘고 있습니다.
주사제 부문은 2025년 111억 달러로 평가되었고, 2035년까지 408억 달러에 달할 것으로 예측됩니다. 소비자 선호도가 자연스러우면서도 빠른 결과를 얻을 수 있는 최소침습적 시술로 이동함에 따라, 이 부문은 계속해서 강한 모멘텀을 유지하고 있습니다. 보툴리눔 제제나 진피 필러를 이용한 시술은 얼굴의 윤곽 형성, 주름 개선, 볼륨 회복을 위해 널리 이용되고 있습니다. 미용에 대한 인식 증가, 젊은 층의 수용성 향상, 남성 소비자의 참여 증가는 세계 시장에서 주사제 시술에 대한 수요를 더욱 강화시키고 있습니다.
2025년 기준, 여성 부문이 시장 점유율의 75.2%를 차지했습니다. 이러한 우위는 미용 시술에 대한 높은 인식, 미용 성형에 대한 수용성 확대, 그리고 피부 관리와 안티에이징 치료에 대한 높은 관심에 기인합니다. 여성들은 외모를 개선하고 젊음을 유지하기 위해 피부 회춘, 주사 요법, 바디 컨투어링, 탄력 치료 등의 시술을 선택하는 것이 일반적입니다. 디지털 미디어, 미용 트렌드, 전문가들의 추천에 의한 영향도 이 계층의 미용 시술 채택을 더욱 촉진하고 있습니다.
2025년 북미의 미용의학 시장은 39.5%의 점유율을 차지했습니다. 이 지역에서는 소비자의 의식 향상, 미용 시술의 기술 발전, 외모에 대한 관심 증가에 힘입어 강력한 성장이 지속될 것으로 예측됩니다. 미용 시술을 적극적으로 찾는 대규모 인구 기반이 지역 수요에 크게 기여하고 있습니다. 고급 미용 서비스 이용 기회 확대와 다양한 연령대의 미용 시술에 대한 수용성 증가는 이 지역 시장 성장을 더욱 촉진하고 있습니다.
자주 묻는 질문
목차
제1장 조사 방법
제2장 주요 요약
제3장 업계 인사이트
제4장 경쟁 구도
제5장 시장 추산 및 예측 : 제품별(2022-2035년)
제6장 시장 추산 및 예측 : 성별(2022-2035년)
제7장 시장 추산 및 예측 : 용도별(2022-2035년)
제8장 시장 추산 및 예측 : 최종 용도별(2022-2035년)
제9장 시장 추산 및 예측 : 지역별(2022-2035년)
제10장 기업 개요
KTH 26.06.10The Global Aesthetic Medicine Market was valued at USD 23.2 billion in 2025 and is estimated to grow at a CAGR of 13.5% to reach USD 80.2 billion by 2035.
The market is witnessing strong growth momentum driven by rising awareness of cosmetic enhancement procedures, continuous advancements in medical aesthetic technologies, and increasing preference for non-invasive treatments. Growing concerns related to obesity and body image are further contributing to market expansion as more individuals seek aesthetic interventions to improve physical appearance. Technological innovation in aesthetic devices and treatment methods is enhancing safety, precision, and outcomes, making procedures more accessible and appealing. In addition, shifting social attitudes toward cosmetic enhancement, combined with increased disposable income and broader acceptance of aesthetic treatments across different age groups, is supporting sustained demand. The expansion of dermatology clinics and specialized cosmetic centers is also improving access to advanced procedures, further strengthening market penetration globally.
| Market Scope | |
|---|---|
| Start Year | 2025 |
| Forecast Year | 2026-2035 |
| Start Value | $23.2 Billion |
| Forecast Value | $80.2 Billion |
| CAGR | 13.5% |
Aesthetic medicine refers to a medical specialty focused on improving physical appearance through surgical, minimally invasive, and non-surgical procedures. It addresses concerns such as wrinkles, scars, excess fat, skin laxity, cellulite, unwanted hair, and uneven pigmentation. These procedures are performed by qualified professionals, including dermatologists, plastic surgeons, and cosmetic practitioners. The rising acceptance of cosmetic enhancement is significantly boosting demand, as more individuals pursue treatments to enhance their appearance and self-confidence. Increasing global obesity rates are also acting as a key growth driver, with more people opting for aesthetic procedures to achieve improved body contouring outcomes beyond traditional lifestyle approaches such as diet and exercise.
The injectable segment was valued at USD 11.1 billion in 2025 and is projected to reach USD 40.8 billion by 2035. This segment continues to gain strong traction as consumer preference shifts toward minimally invasive procedures that deliver quick results with natural-looking outcomes. Treatments involving botulinum-based products and dermal fillers are widely used for facial enhancement, wrinkle reduction, and volume restoration. Rising aesthetic awareness, increased acceptance among younger populations, and growing participation from male consumers are further strengthening demand for injectable treatments across global markets.
The female segment accounted for 75.2% share in 2025. This leadership is attributed to higher awareness of cosmetic procedures, greater openness toward aesthetic enhancement, and strong interest in skincare and anti-aging treatments. Women commonly opt for procedures such as skin rejuvenation, injectables, body contouring, and tightening treatments to enhance appearance and maintain youthful looks. Influences from digital media, beauty trends, and professional recommendations further encourage the adoption of aesthetic procedures across this demographic.
North America Aesthetic Medicine Market held 39.5% in 2025. The region continues to experience strong growth supported by rising consumer awareness, technological advancements in aesthetic procedures, and increasing emphasis on physical appearance. A large population base actively seeking cosmetic treatments contributes significantly to regional demand. The expanding availability of advanced aesthetic services and growing acceptance of cosmetic enhancement across diverse age groups further strengthen market growth in the region.
Major companies operating in the Global Aesthetic Medicine Market include Johnson & Johnson, Merz Pharma, Bausch Health Companies Inc., Boston Scientific Corporation, Cutera, El.En. S.p.A., GC Aesthetics plc, Sisram Medical Ltd, Venus Concept, Sciton, Inc., SharpLight Technologies Inc, Huadong Medicine Co., Ltd, Hahn & Company, Apax Partners, and Vitruvian Partners LLP. Companies in the aesthetic medicine market are focusing on continuous innovation in minimally invasive and non-invasive treatment technologies to enhance safety, effectiveness, and patient satisfaction. They are increasing investments in research and development to introduce advanced injectables, energy-based devices, and combination therapies. Strategic partnerships with dermatology clinics, cosmetic surgery centers, and medical spa chains are helping expand market reach and strengthen distribution networks. Firms are also prioritizing product portfolio expansion through mergers and acquisitions to gain access to new technologies and geographic markets. Growing emphasis on clinical training and practitioner education programs is improving procedural adoption rates.
Table of Contents
Chapter 1 Research Methodology
- 1.1 Research approach
- 1.2 Quality commitments
- 1.2.1 GMI AI policy & data integrity commitment
- 1.2.1.1 Source consistency protocol
- 1.2.1 GMI AI policy & data integrity commitment
- 1.3 Research trail & confidence scoring
- 1.3.1 Research trail components
- 1.3.2 Scoring components
- 1.4 Data collection
- 1.4.1 Partial list of primary sources
- 1.5 Data mining sources
- 1.5.1 Paid sources
- 1.5.1.1 Sources, by region
- 1.5.1 Paid sources
- 1.6 Base estimates and calculations
- 1.6.1 Base year calculation for any one approach
- 1.7 Forecast model
- 1.7.1 Quantified market impact analysis
- 1.7.1.1 Mathematical impact of growth parameters on forecast
- 1.7.1 Quantified market impact analysis
- 1.8 Research transparency addendum
- 1.8.1 Source attribution framework
- 1.8.2 Quality assurance metrics
- 1.8.3 Our commitment to trust
Chapter 2 Executive Summary
- 2.1 Industry 3600 synopsis
- 2.2 Key market trends
- 2.2.1 Product trends
- 2.2.2 Gender trends
- 2.2.3 Application trends
- 2.2.4 End use trends
- 2.2.5 Regional trends
- 2.3 CXO perspectives: Strategic imperatives
Chapter 3 Industry Insights
- 3.1 Industry ecosystem analysis
- 3.2 Industry impact forces
- 3.2.1 Growth drivers
- 3.2.1.1 Increasing awareness regarding aesthetic procedures.
- 3.2.1.2 Technological advancements associated with medical aesthetic devices.
- 3.2.1.3 Rising prevalence of obesity.
- 3.2.1.4 Increasing adoption of non-invasive procedures.
- 3.2.2 Industry pitfalls and challenges
- 3.2.2.1 High cost associated with aesthetic procedures.
- 3.2.2.2 Lack of reimbursement and stringent regulatory scenario.
- 3.2.3 Market opportunities
- 3.2.3.1 Expansion of aesthetic procedures among men
- 3.2.3.2 Expansion in regenerative aesthetics (PRP, stem-cell based therapies)
- 3.2.1 Growth drivers
- 3.3 Growth potential analysis
- 3.4 Regulatory landscape (Driven by primary research)
- 3.4.1 North America
- 3.4.2 Europe
- 3.4.3 Asia Pacific
- 3.4.4 Latin America
- 3.4.5 Middle East and Africa
- 3.5 Technology landscape (Driven by primary research)
- 3.5.1 Current technological trends
- 3.5.1.1 Fractional CO2 laser for acne scars and skin rejuvenation
- 3.5.1.2 Microneedle radiofrequency for skin rejuvenation
- 3.5.2 Emerging technologies
- 3.5.2.1 High-intensity focused ultrasound for facial rejuvenation and body contouring
- 3.5.2.2 Regenerative bio stimulation therapies for rejuvenation
- 3.5.1 Current technological trends
- 3.6 Future market trends (Driven by primary research)
- 3.7 Impact of AI and Generative AI on the market (Driven by primary research)
- 3.8 Pricing trend analysis (Driven by primary research)
- 3.9 Patent analysis
- 3.10 Porter's analysis
- 3.11 PESTEL analysis
Chapter 4 Competitive Landscape, 2025
- 4.1 Introduction
- 4.2 Company market share analysis
- 4.2.1 Global
- 4.2.2 North America
- 4.2.3 Europe
- 4.2.4 Asia Pacific
- 4.3 Company matrix analysis
- 4.4 Competitive analysis of major market players
- 4.5 Competitive positioning matrix
- 4.6 Key developments
- 4.6.1 Mergers and acquisitions
- 4.6.2 Partnerships and collaborations
- 4.6.3 New product launches
- 4.6.4 Expansion plans
Chapter 5 Market Estimates and Forecast, By Product, 2022 - 2035 ($ Mn)
- 5.1 Key trends
- 5.2 Energy-based devices
- 5.2.1 Laser-based aesthetic device
- 5.2.2 Radiofrequency (RF)-based aesthetic device
- 5.2.3 Light-based aesthetic device
- 5.2.4 Ultrasound aesthetic device
- 5.2.5 Other energy-based products
- 5.3 Injectables
- 5.3.1 Botulinum toxin
- 5.3.2 Dermal fillers (HA & Non-HA)
- 5.3.3 Collagen stimulators
- 5.4 Implants
- 5.4.1 Breast implants
- 5.4.2 Facial implants
- 5.4.3 Other implants
- 5.5 Skincare products & accessories
Chapter 6 Market Estimates and Forecast, By Gender, 2022 - 2035 ($ Mn)
- 6.1 Key trends
- 6.2 Male
- 6.3 Female
Chapter 7 Market Estimates and Forecast, By Application, 2022 - 2035 ($ Mn)
- 7.1 Key trends
- 7.2 Facial aesthetics and anti-aging
- 7.3 Skin resurfacing and rejuvenation
- 7.4 Body contouring and fat reduction
- 7.5 Hair removal
- 7.6 Scar and pigmentation treatment
- 7.7 Other applications
Chapter 8 Market Estimates and Forecast, By End use, 2022 - 2035 ($ Mn)
- 8.1 Key trends
- 8.2 Hospitals
- 8.3 Ambulatory surgical centers
- 8.4 Beauty centers and medical spas
- 8.5 Dermatology clinics
Chapter 9 Market Estimates and Forecast, By Region, 2022 - 2035 ($ Mn)
- 9.1 Key trends
- 9.2 North America
- 9.2.1 U.S.
- 9.2.2 Canada
- 9.3 Europe
- 9.3.1 Germany
- 9.3.2 UK
- 9.3.3 France
- 9.3.4 Spain
- 9.3.5 Italy
- 9.3.6 Netherlands
- 9.4 Asia Pacific
- 9.4.1 China
- 9.4.2 Japan
- 9.4.3 India
- 9.4.4 Australia
- 9.4.5 South Korea
- 9.5 Latin America
- 9.5.1 Brazil
- 9.5.2 Mexico
- 9.5.3 Argentina
- 9.6 Middle East and Africa
- 9.6.1 South Africa
- 9.6.2 Saudi Arabia
- 9.6.3 UAE
Chapter 10 Company Profiles
- 10.1 Global players
- 10.1.1 Boston Scientific Corporation
- 10.1.2 Bausch Health Companies Inc.
- 10.1.3 Cutera
- 10.1.4 Johnson & Johnson
- 10.1.5 Merz Pharma
- 10.1.6 Sisram Medical Ltd
- 10.1.7 Venus Concept
- 10.2 Regional players
- 10.2.1 El.En. S.p.A
- 10.2.2 Huadong Medicine Co., Ltd
- 10.2.3 Sciton, Inc.
- 10.2.4 SharpLight Technologies Inc
- 10.3 Emerging players
- 10.3.1 Apax Partners
- 10.3.2 GC Aesthetics plc
- 10.3.3 Vitruvian Partners LLP
- 10.3.4 Hahn & Company
